Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?

Abstract

This model could be a helpful tool for the surgeon to help in predicting which cases have a higher likelihood of achieving a pathologically complete response and therefore selecting those who may benefit from a post-neoadjuvant chemotherapy sentinel lymph node biopsy and avoid unnecessary axillary lymphadenectomy.